2 weeks ago
China's OneGenome AI Tool Helps Screen DNA for Rare Diseases
Some people have rare diseases that doctors find very hard to figure out, and finding an answer can take many years.
Inside our bodies, DNA acts like a giant instruction book made of about 3 billion tiny parts.
Scientists in China built a smart computer program called OneGenome that can read this DNA and find tiny changes.
OneGenome uses two kinds of artificial intelligence: one that understands DNA and one that understands medical language.
It helps doctors connect DNA changes with a patient's symptoms and medical research.
The program won an award from the International Telecommunication Union at a big United Nations technology meeting in July 2026.
However, OneGenome is not a robot doctor — it only gives doctors helpful hints.
Finding a DNA change does not always mean a person is sick, so doctors must check the results carefully.
The makers warn that people should not upload their DNA to an AI program and expect a diagnosis on their own.
Before OneGenome is used in hospitals everywhere, it needs more testing, privacy protection, and careful oversight by doctors.
Chinese researchers developed OneGenome, an open-source AI system that combines the Genos genomic foundation model with large language model capabilities.
OneGenome is designed to help interpret DNA sequences and identify genetic changes that may be relevant to rare diseases.
According to its developers, the system outperformed general-purpose AI models and conventional gene models in several diagnostic and medication-guidance tests.
In July 2026, OneGenome received the Innovate for Impact Use Case Award from the International Telecommunication Union at the UN AI for Good Global Summit.
Developers say OneGenome is a decision-support tool, not an AI doctor, and it still needs independent validation, privacy safeguards, and clinical oversight.
- Who
- Chinese researchers from BGI-Research and Zhejiang Lab, who developed the OneGenome AI system.
- What
- An open-source AI system called OneGenome that combines the Genos genomic foundation model with large language model capabilities to help interpret DNA variants relevant to rare diseases.
- Where
- Developed in China; the award was presented at the UN AI for Good Global Summit.
- When
- Reported in July 2026, when OneGenome received the Innovate for Impact Use Case Award at the UN AI for Good Global Summit.
- Why
- To help clinicians interpret vast amounts of genomic and medical information and potentially shorten the years-long 'diagnostic odyssey' faced by rare disease patients.
Key facts
- System name
- OneGenome
- Type
- Open-source AI system
- Core components
- Genos genomic foundation model + large language model capabilities
- Genos developers
- BGI-Research and Zhejiang Lab
- Award
- Innovate for Impact Use Case Award from the International Telecommunication Union, UN AI for Good Global Summit, July 2026
- Human genome size
- Roughly 3 billion DNA base pairs
- Role
- Decision-support tool, not an AI doctor
- Related AI system
- DeepRare (Shanghai Jiao Tong University and Xinhua Hospital)
Sources
Related news
New nonprofit seeks reusable gene therapies for ultrarare diseases
HaystackAnalytics Expands Genomic Centers for Infectious Disease Diagnostics
Indian Startup Uses Generative AI to Design Gene Editors
AI Helps Reveal Hidden Heart Risks Between Heartbeats
Gujarat launches DNA-based sports talent hunt for 2030 Commonwealth Games
